Literature DB >> 21715

Development of hematopoietic spleen colonies in nonirradiated genetically normal mice.

Y Kitamura, M Tamai, Y Miyano, M Shimada.   

Abstract

The question as to whether prior irradiation or injection of cytotoxic drugs is essential for the development of spleen colonies was examined in genetically normal mice. Mixtures of lymph node and bone marrow cells from C57BL mice were injected into (C57BL X CBA-T6T6) F1 hybrid mice without pretreatment. Hematopoietic nodules were observed in the spleens of F1 hybrid mice killed 18 days after injection. The average number of nodules increased linearly with increased numbers of injected bone marrow cells. Hematopoietic stem cells (CFU-S) and dividing cells in the nodules were shown to be of C57BL origin. Histologic examination showed that erythroid cell colonies predominated over granulocytic cell colonies. These results suggest that any kind of treatment that causes the depletion of CFU-S in the spleen of hosts would provide a suitable environment for the production of colonies by transplanted CFU-S.

Entities:  

Mesh:

Year:  1977        PMID: 21715

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  3 in total

1.  Increase in histidine decarboxylase activity in skin of genetically mast-cell-deficient W/Wv mice after application of phorbol 12-myristate 13-acetate: evidence for the presence of histamine-producing cells without basophilic granules.

Authors:  Y Taguchi; K Tsuyama; T Watanabe; H Wada; Y Kitamura
Journal:  Proc Natl Acad Sci U S A       Date:  1982-11       Impact factor: 11.205

2.  Different effects of dimethylbenz(alpha)anthracene and tetradecanoylphorbol acetate on differentiation of mast cells in the skin of mice.

Authors:  T Sonoda; K Tsuyama; Y Kitamura; H Tanooka
Journal:  Am J Pathol       Date:  1982-03       Impact factor: 4.307

3.  Distribution of mast-cell precursors in hematopoeitic and lymphopoietic tissues of mice.

Authors:  Y Kitamura; M Shimada; S Go; H Matsuda; K Hatanaka; M Seki
Journal:  J Exp Med       Date:  1979-09-19       Impact factor: 14.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.